Expression of matrix metalloproteinase-9 in the neoplastic and interstitial inflammatory infiltrate cells in the different histopathological types of esophageal cancer

Folia Histochemica et Cytobiologica

Volumn 46, Issue 4, 2008, Pages 471-477

  Mroczko, Barbara ^a   Kozłowski, Mirosław ^a   Groblewska, Magdalena ^a   Łukaszewicz, Marta ^a   Nikliński, Jacek ^a   Laudański, Jerzy ^a   Chyczewski, Lech ^a   Szmitkowski, Maciej ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Esophageal cancer; Matrix metalloproteinases; MMP 9

Indexed keywords

GELATINASE B;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER INVASION; CANCER STAGING; CELL INFILTRATION; CLINICAL ARTICLE; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; LYMPH NODE METASTASIS; MALE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; TISSUE TYPES; TUMOR VOLUME; CLASSIFICATION; ENZYMOLOGY; ESOPHAGUS TUMOR; INFLAMMATION; METABOLISM; MIDDLE AGED; PATHOLOGY;

AGED; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; INFLAMMATION; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED;

EID: 60549102861     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10042-008-0065-9     Document Type: Article

References (15)

1. Vihinen P, Kähäri V-M. Matrix metalloproteinases in cancer: prognostic markerss and therapeutic targets. Int J Cancer. 2002;99:157-66.
2. Gu ZD, Chen KN, Li M, et al. Clinical significance of matrix metalloproteinase-9 expression in esophageal squamous cell carcinoma. World J Gastroenterol. 2005;11:871-874.
3. Crew KD, Neugut AI. Epidemiology of upper gastrointestinal malignancies. Semin Oncol. 2004,31:450-64.
4. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin. 1999;49:8-31.
5. Vallböhmer D, Lenz H-J. Predictive and prognostic molecular markers in outcome of esophageal cancer. Dis Esophagus. 2006;19:425-32.
6. Murray GI, Duncan ME, O'Neil P, et al. Matrix metalloproteinase-1 is associated with poor prognosis in esophageal cancer. J Pathol. 1998;185:256-61.
7. El-Shahat M, Lotfy M, Fahmy L, et al. Prognostic value of microvessel density, matrix metalloproteinase-9 and p53 protein expression in esophageal cancer. J Egypt Natl Cancer Inst. 2004;16:224-30.
8. Samantaray S, Sharma R, Chattopadhyaya TK, et al. Increased expression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma. J Cancer Res Clin Oncol. 2004; 130:37-44.
9. Tanioka Y, Yoshida T, Yagawa T, et al. Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer. Br J Cancer. 2003;89:2116-21.
10. Mroczko B, Kozłowski M, Groblewska M, et al. The diagnostic value of the measurement of matrix metalloproteinase-476 9 (MMP-9), squamous cell cancer antigen (SCC) and carcinoembryonic antigen (CEA) in the sera of esophageal cancer patients. Clin Chim Acta. 2008;389:61-6.
11. Sobin LH, Wittenkind C. International Union Against Cancer (UICC) TNM classification of malignant tumours, 5th edition. New York: Willey-Liss;1997.
12. Bollschweiler E, Schrösder W, Hölscher AH, Siewert JR. Preoperative risk analysis in patients with adenocarcinoma or squamous cell carcinoma of the oesophagus. Br J Surg. 2000; 87:1106-10.
13. Biswas C, Zhang Y, DeCastro R, et al. The human tumor cell-drived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res. 1995;55:434-9.
14. Terris B, Baldin V, Dubois S, et al. PML nuclear bodies are general targets for inflammation and cell proliferation. Cancer Res. 1995;55:1590-7.
15. Suzuki Y, Ohtani H, Mizoi T, et al. Cell adhesion molecule expression by vascular endothelial cells as an immune/inflammatory reaction in human colon carcinoma. Jpn J Cancer Res. 1995;86:585-93.